We’ve come a long way from the turn of the 20th century, when gastrointestinal (GI) infections were the third-leading cause of death in Americans.
However, according to the GI Alliance, 62 million Americans are diagnosed each year with digestive disorders.
By 2026, analysts expect the market to almost double — increasing at a compound annual growth rate of 8.2%! That’s not 8% total, folks — that’s 8% every year.
Today’s Power Stock should see solid gains as it capitalizes on this medical trend…
The post Biopharma Co. to Help Millions of Americans — and Profit in the Process appeared first on Money & Markets, LLC.